201 related articles for article (PubMed ID: 23285003)
1. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.
Markaki A; Kyriazis J; Stylianou K; Fragkiadakis GA; Perakis K; Margioris AN; Ganotakis ES; Daphnis E
PLoS One; 2012; 7(12):e52350. PubMed ID: 23285003
[TBL] [Abstract][Full Text] [Related]
2. Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study.
Tung CW; Hsu YC; Shih YH; Lin CL
PLoS One; 2015; 10(10):e0141058. PubMed ID: 26474473
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
4. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients.
Ohashi N; Kato A; Misaki T; Sakakima M; Fujigaki Y; Yamamoto T; Hishida A
Intern Med; 2008; 47(6):485-91. PubMed ID: 18344634
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients.
Bakkaloglu SA; Buyan N; Funahashi T; Pasaoglu H; Elhan AH; Hasanoglu E; Soylemezoglu O
Perit Dial Int; 2005; 25(4):357-61. PubMed ID: 16022092
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin levels and clinical outcomes among haemodialysis patients.
Rao M; Li L; Tighiouart H; Jaber BL; Pereira BJ; Balakrishnan VS;
Nephrol Dial Transplant; 2008 Aug; 23(8):2619-28. PubMed ID: 18334528
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Buemi M; Nicocia G; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y
J Am Soc Nephrol; 2002 Jan; 13(1):134-141. PubMed ID: 11752030
[TBL] [Abstract][Full Text] [Related]
8. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease.
Hyun YY; Lee KB; Oh KH; Ahn C; Park SK; Chae DW; Yoo TH; Cho KH; Kim YS; Hwang YH;
Nutrition; 2017 Jan; 33():254-260. PubMed ID: 27692989
[TBL] [Abstract][Full Text] [Related]
10. Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients.
Spoto B; Mattace-Raso F; Sijbrands E; Pizzini P; Cutrupi S; D'Arrigo G; Tripepi G; Zoccali C; Mallamaci F
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv181-7. PubMed ID: 23975745
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
12. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
13. Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
Li L; Streja E; Rhee CM; Mehrotra R; Soohoo M; Brunelli SM; Kovesdy CP; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Dec; 66(6):1047-55. PubMed ID: 26184377
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].
Sasaki N; Takeda S; Saito T; Ando Y; Kusano E
Nihon Jinzo Gakkai Shi; 2009; 51(4):476-83. PubMed ID: 19601557
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and end-stage renal disease.
Markaki A; Psylinakis E; Spyridaki A
Hormones (Athens); 2016 Jul; 15(3):345-354. PubMed ID: 27838604
[TBL] [Abstract][Full Text] [Related]
17. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
Block GA; Hulbert-Shearon TE; Levin NW; Port FK
Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
[TBL] [Abstract][Full Text] [Related]
18. Hypomagnesaemia in haemodialysis is associated with increased mortality risk: its relationship with dialysis fluid.
Pérez-García R; Jaldo MT; Puerta M; Ortega M; Corchete E; de Sequera P; Martín-Navarro JA; Albalate M; Alcázar R
Nefrologia (Engl Ed); 2020; 40(5):552-562. PubMed ID: 32651086
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology.
Beige J; Heipmann K; Stumvoll M; Körner A; Kratzsch J
Expert Opin Ther Targets; 2009 Feb; 13(2):163-73. PubMed ID: 19236235
[TBL] [Abstract][Full Text] [Related]
20. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
Lacson E; Wang W; Ma L; Passlick-Deetjen J
Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
